Pharma Commercialisation Services
Results Healthcare has a long and distinguished history supporting transactions for companies that service the commercialisation of pharmaceuticals and devices by pharma, generic and medical device companies.
Results executed its first transaction in this sector in 1998 with the sale of Adelphi to Omnicom Group. More recently we’ve worked on the sale of iSafety Systems, an Indian pharmacovigilance company which we sold to ProPharma Group, a US company providing drug regulatory services to pharma, generic and biotech companies, in 2021. Between these dates Results Healthcare has been involved in many transactions with a wide range of companies (founder owned or PE-backed) that provide expert services including digital transformation, consulting, analytics, market access, salesforce training, PR and media, to the healthcare industry.
Pharma Commercialisation Services Deals
Pharma Licensing: the why the how and a few things to get right
Platform or asset licensing has increasingly been utilised across the bio-pharmaceutical industry to achieve Corporate objectives by sharing intellectual property (IP). IP includes patents and know-how and third-party proprietary technologies, compounds and products, and can be used to build on existing therapeutic areas, expand into different geographies or to diversify portfolios. A pharma licensing deal […]
Pharma Commercialisation Services Update – September 2022
Welcome to our latest update on the outsourced Pharma Commercialisation Services sector. As well as our usual update on M&A activity, this report takes a deep dive into one of the biggest challenges businesses are currently facing – the War for Talent. A phrase first coined by McKinsey in the late ’90s but one that […]
Pharma Commercialisation Services Update – February 2022
We are pleased to introduce you to the first of our regular sector updates on the outsourced pharma commercialisation sector. For some time, Results Healthcare has been producing sector updates and whitepapers on the two other major areas pharmaceutical companies choose to outsource: manufacturing and research. This report focuses on commercialisation, encompassing Healthcare Marketing, Market […]